NCT06006026View on ClinicalTrials.gov

The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery

NARecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

May 10, 2024

Study Completion Date

May 20, 2024

Conditions
Colorectal Cancer
Interventions
DRUG

Ropivacaine Hydrochloride 10 MG/ML [Naropin]

According to the specified dosage, dilute 1% ropivacaine to 0.2% and inject 1/2 of the total amount on each side.

Trial Locations (1)

Unknown

RECRUITING

West China hospital, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER